Effective July 15, 2010, the statutes and regulations governing the practice of dentistry in the Commonwealth of Kentucky have changed.
In a proactive measure to advance the Commonwealth of Kentucky's conservation initiative, the Kentucky Board of Dentistry is providing electronic access to the Kentucky Dental Practice Act through the internet. Please access the laws by using the links below to review the statutes and regulations that govern dentistry in Kentucky.
Recent Changes to KBD Regulations
As the agency with jurisdiction, the Board has the authority to issue Advisory Opinions to interpret the statutes and regulations governing the practice of dentistry in the Commonwealth of Kentucky.
Prior to the law change on July 15, 2010, the Board issued many Opinions and Declaratory Rulings; as those rulings were interpretations of statutes and regulations that have now been repealed, any ruling dated before July 15, 2010 is no longer applicable law.
For information on how to submit an Advisory Opinion request, or to see an index of published Advisory Opinions, please see our
Advisory Opinions page.
Drug Enforcement Agency Reschedules Hydrocodone Combination Products
The U.S. Drug Enforcement Administration (DEA) published a final rule in the Federal Register advising that it is rescheduling hydrocodone combination products from Schedule III to Schedule II of the Controlled Substances Act. This DEA rescheduling will take effect on October 6, 2014. A full discussion of this action can be found at the following link:
This rescheduling of hydrocodone combination products from Schedule III to Schedule II does not preclude dentists with valid DEA prescribing certificates from prescribing hydrocodone combination products. However, this change does require an inquiry of the KASPER system in all instances before prescribing hydrocodone combination products.
Under Kentucky Dental Regulations (201 KAR 8:540, Section 4(2), a dentist is not required to obtain and review a KASPER report if prescribing a Schedule III controlled substance or one of the listed Schedule IV controlled substances after the performance of oral surgery provided no more than a seventy-two (72) hour supply of that controlled substance is prescribed. Therefore, the new DEA rule will not affect the ability to prescribe a Schedule III or one of the listed Schedule IV controlled substances after the performance of oral surgery. In summary, as a result of action by the DEA, effective October 6, 2014, dentists will be required to obtain and review a KASPER report before prescribing a hydrocodone combination product.